Citius Pharmaceuticals, Inc. SEC filings CTXR
Citius Pharmaceuticals, Inc. has 638 filings in SEC EDGAR's recent list, going back to Nov 23, 2010. Its latest annual report, Form ARS, was filed on Feb 24, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 14, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (other events). The company's fiscal year ends on September 30.
| Form | Description | Filed | Period |
|---|---|---|---|
| ARS | Annual report to shareholders | Feb 24, 2026 | Sep 30, 2025 |
| 10-K/A | Amended annual report | Jan 28, 2026 | Sep 30, 2025 |
| 10-K | Annual report | Dec 23, 2025 | Sep 30, 2025 |
| 10-K/A | Amended annual report | Jan 27, 2025 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Jan 27, 2025 | Sep 30, 2024 |
| 10-K | Annual report | Dec 27, 2024 | Sep 30, 2024 |
| ARS | Annual report to shareholders | Jan 26, 2024 | Sep 30, 2023 |
| 10-K | Annual report | Dec 29, 2023 | Sep 30, 2023 |
| 10-K | Annual report | Dec 22, 2022 | Sep 30, 2022 |
| 10-K | Annual report | Dec 15, 2021 | Sep 30, 2021 |
| 10-K | Annual report | Dec 16, 2020 | Sep 30, 2020 |
| 10-K | Annual report | Dec 16, 2019 | Sep 30, 2019 |
| 10-K | Annual report | Dec 11, 2018 | Sep 30, 2018 |
| 10-K | Annual report | Dec 13, 2017 | Sep 30, 2017 |
| 10-K | Annual report | Dec 23, 2016 | Sep 30, 2016 |
| 10-K | Annual report | Dec 14, 2015 | Sep 30, 2015 |
| 10-KT | Transition report | Dec 29, 2014 | Sep 30, 2014 |
| 10-K | Annual report | Feb 6, 2014 | Sep 30, 2013 |
| 10-K | Annual report | Jan 15, 2013 | Sep 30, 2012 |
| 10-K | Annual report | Jan 13, 2012 | Sep 30, 2011 |
Showing 20 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CTXR (Nasdaq)
- Fiscal year ends
- September 30
- Incorporated in
- NV
- Headquarters
- Cranford, NJ
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1506251
- Former names
- Trail One, Inc. (until Sep 18, 2014); TrailOne, Inc. (until Jan 21, 2011)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.